High-Dose Allopurinol Improves Endothelial Function by Profoundly Reducing Vascular Oxidative Stress and Not by Lowering Uric Acid
Top Cited Papers
- 5 December 2006
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 114 (23), 2508-2516
- https://doi.org/10.1161/circulationaha.106.651117
Abstract
Background— Allopurinol has been shown to improve endothelial function in chronic heart failure. This study aimed to establish its mechanism of action and to construct a dose–response curve for the effect of allopurinol. Methods and Results— Two randomized, placebo-controlled, double-blind, crossover studies were performed for 1 month on patients with New York Heart Association Class II–III chronic heart failure, comparing 300 mg allopurinol, 600 mg allopurinol, and placebo for the first study and 1000 mg probenecid versus placebo in the second study. Endothelial function was assessed by standard forearm venous occlusion plethysmography. Allopurinol 600 mg/d significantly increased forearm blood flow response to acetylcholine compared with both allopurinol 300 mg/d and placebo (% change in forearm blood flow [mean±SEM]: 240.31±38.19% versus 152.10±18.21% versus 73.96±10.29%, P Conclusions— For the first time, we have shown that a steep dose–response relationship exists between allopurinol and its effect on endothelial function. We also showed that the mechanism of improvement in endothelial function with allopurinol lies in its ability to reduce vascular oxidative stress and not in urate reduction. The reduction in vascular oxidative stress was profound because high-dose allopurinol totally abolished the oxidative stress that was sensitive to the high-dose vitamin C that was used in this study.This publication has 27 references indexed in Scilit:
- Vitamin C blocks vascular dysfunction and release of interleukin-6 induced by endothelin-1 in humans in vivoAtherosclerosis, 2007
- Tetrahydrobiopterin correctsEscherichia coliendotoxin-induced endothelial dysfunctionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patientsAmerican Heart Journal, 2005
- Endothelial dysfunction: clinical strategies for treating oxidant stressAmerican Heart Journal, 2003
- Serum Urate as an Independent Predictor of Poor Outcome and Future Vascular Events After Acute StrokeStroke, 2003
- Vitamin C improves resistance but not conduit artery endothelial function in patients with chronic renal failureKidney International, 2003
- Effects of Xanthine Oxidase Inhibition With Allopurinol on Endothelial Function and Peripheral Blood Flow in Hyperuricemic Patients With Chronic Heart FailureCirculation, 2002
- Pharmacokinetics and pharmacodynamics of allopurinol in elderly and young subjectsBritish Journal of Clinical Pharmacology, 1999
- How reproducible is bilateral forearm plethysmography?British Journal of Clinical Pharmacology, 1998
- Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjectsBritish Journal of Clinical Pharmacology, 1996